Geraniol suppresses prostate cancer growth through down-regulation of E2F8.

Geraniol suppresses prostate cancer growth through down-regulation of E2F8.
复制标题

DOI:
10.1002/cam4.864
复制
发表时间:
2016-10
期刊:
影响因子:
4
通讯作者:
Jeon, Ju-Hong
Jeon, Ju-Hong
中科院分区:
医学3区
文献类型:
--
作者:
Lee, Sanghoon;Park, Yu Rang;Kim, Su-Hwa;Park, Eun-Jung;Kang, Min Ji;So, Insuk;Chun, Jung Nyeo;Jeon, Ju-Hong

文献摘要

参考文献

被引文献

相似文献

香叶醇是一种无环膳食单萜,已被发现可以抑制癌症的生存和生长。然而,香叶醇抗肿瘤作用的分子机制尚未在全基因组水平上进行研究。在这项研究中,我们分析了从香叶醇处理的前列腺癌细胞中获得的微阵列数据。与芳樟醇相比,香叶醇可以改变基因表达谱,主要下调细胞周期相关的基因特征。芳樟醇是另一种结构相似的单萜,不会引起明显的表型变化。使用前列腺癌特异性调控相互作用组进行主调控分析,发现转录因子E2F8作为特异性靶分子调控香叶醇特异性细胞周期特征。随后的实验证实,香叶醇下调E2F8的表达,而E2F8的下调足以通过诱导G2/M阻滞来抑制细胞生长。流行病学分析显示,E2F8在转移性前列腺癌中表达上调,并与预后不良相关。这些结果表明E2F8在前列腺癌细胞中是一个重要的调控细胞周期和存活的转录调控因子。因此,我们的研究提供了E2F8在前列腺癌生物学和治疗中的作用。
Geraniol, an acyclic dietary monoterpene, has been found to suppress cancer survival and growth. However, the molecular mechanism underlying the antitumor action of geraniol has not been investigated at the genome‐wide level. In this study, we analyzed the microarray data obtained from geraniol‐treated prostate cancer cells. Geraniol potently altered a gene expression profile and primarily down‐regulated cell cycle‐related gene signatures, compared to linalool, another structurally similar monoterpene that induces no apparent phenotypic changes. Master regulator analysis using the prostate cancer‐specific regulatory interactome identified that the transcription factor E2F8 as a specific target molecule regulates geraniol‐specific cell cycle signatures. Subsequent experiments confirmed that geraniol down‐regulated E2F8 expression and the knockdown of E2F8 was sufficient to suppress cell growth by inducing G2/M arrest. Epidemiological analysis showed that E2F8 is up‐regulated in metastatic prostate cancer and associated with poor prognosis. These results indicate that E2F8 is a crucial transcription regulator controlling cell cycle and survival in prostate cancer cells. Therefore, our study provides insight into the role of E2F8 in prostate cancer biology and therapeutics.
DOI: 10.1093/bioinformatics/btr260
发表时间: 2011-06-15
期刊: BIOINFORMATICS
影响因子: 5.8
作者:
Liberzon, Arthur;Subramanian, Aravind;Mesirov, Jill P.
通讯作者: Mesirov, Jill P.
DOI: 10.1016/j.bbrc.2012.05.010
发表时间: 2012-06-08
影响因子: 3.1
作者:
Kim, Su-Hwa;Lee, Sanghoon;Jeon, Ju-Hong
通讯作者: Jeon, Ju-Hong
DOI: 10.1016/j.ccr.2010.05.026
发表时间: 2010-07-13
期刊: Cancer cell
影响因子: 50.3
作者:
Taylor BS;Schultz N;Hieronymus H;Gopalan A;Xiao Y;Carver BS;Arora VK;Kaushik P;Cerami E;Reva B;Antipin Y;Mitsiades N;Landers T;Dolgalev I;Major JE;Wilson M;Socci ND;Lash AE;Heguy A;Eastham JA;Scher HI;Reuter VE;Scardino PT;Sander C;Sawyers CL;Gerald WL
通讯作者: Gerald WL
DOI: 10.1158/0008-5472.can-09-3082
发表时间: 2010-01-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Deng, Qing;Wang, Qun;Han, Ze-Guang
通讯作者: Han, Ze-Guang
DOI: 10.3892/ijo.2016.3427
发表时间: 2016-05
影响因子: 5.2
作者:
Cho M;So I;Chun JN;Jeon JH
通讯作者: Jeon JH